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Background: Managing an outbreak of gastroenteritis on
board a cruise ship while minimising disruption to passen-
gers’ enjoyment is difﬁcult. This can be more complex
with international cruises. We describe epidemiological
investigation and control of an outbreak of Norovirus on
an international cruise around the British Isles and the
Netherlands managed through an international multi-agency
incident control team.
Methods: A cohort study was conducted using information
from lists routinely collected by the cruise ship to assess the
possible sources of exposures.
Results: A total of 191 of the 1,194 passengers (16%)
and 5 crew (1%) became ill with gastrointestinal symptoms.
Norovirus was identiﬁed through PCR at one of the ports
of call. Attack rate was higher among passengers staying in
the main deck (RR 3.41, 95% CI 1.47- 7.94), which houses
both passengers’ cabins and leisure facilities (e.g. shops).
Also, passengers who went on one of the organised coach
tours where there were symptomatic passengers were at
increased risk of infection (RR 2.14, CI 1.51-3.03).
An international multi-agency Outbreak Control Group,
involving port health authorities and public health agencies
in the ports of call, was convened to oversee control mea-
sure and advice the incident management team on board the
ship. This allowed continuity, ensuring that port health ofﬁ-
cers inspecting the ship at each port were aware of what had
been previously recommended and could monitor progress.
Conclusion: Controlling outbreaks on board a cruise can
be complex when the ship moves from one country to
another and the leadership of the investigation changes. To
ensure that an outbreak is appropriately managed, multina-
tional outbreak control groups are needed with one agency
taking the lead throughout the outbreak. International
agreement between public health authorities in different
countries is needed.
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Background: Medical tourism, foreign travel for the pur-
ose of seeking medical treatment, is an important new
evelopment in healthcare. Medical tourism is a world-wide,
ultibillion dollar phenomenon that is expected to grow
ubstantially in the next 5-10 years. To provide a foundation
or future investigations, a systematic review was conducted
o identify and evaluate current data onmedical tourism and
ssociated health impacts.
Methods: PubMed, EMBASE and Medline databases and
he World Wide Web were searched to identify studies of
edical tourism from 1990-2009 containing data.
Results: 44 studies were identiﬁed. 75% (n = 33) were
eports oncomplications associated with medical tourism
or: commercial organ transplantation (n = 30), cosmetic
urgery (n = 1), dental care (n = 1), and fertility treat-
ents (n = -1). There were 9 (20%) surveys of travelers
nd/or medical tourism providers, and 2 (4%) business
tudies. Methodologies used were primarily retrospective
ecord reviews (75%) and interview surveys (23%). Stud-
es of commercial organ transplantation reviewed 2506
ases, primarily kidney (92%) and liver (8%) transplants.
hina and India were the most frequent transplant desti-
ations. Studies’ results suggest an apparent increase in
‘transplant tourism’’ from 1990-2009, and higher incidence
f post-operative tissue rejection and severe infectious
omplications among transplant tourists compared to other
ransplant patients. These studies are limited by lack of
enominator data for transplant tourism, exclusive focus
n complications, survivorship bias, and the possibility that
ransplant touristsmay not be representative of all medical
ourists. Business studies calculate widely varying estimates
f the frequency of medical tourism, ranging from 60,000-
50,000 medical travelers annually. These studies are lim-
ted by variability in the deﬁnitions and methodologies used
o study medical tourism. Survey studies are limited by lit-
le or no data on treatment(s) received, reasons for seeking
oreign healthcare, or treatment outcomes.
Conclusion: Current epidemiological data on medical
ourism are limited. Basic questions such as the preva-
ence of medical tourism and associated complication rates
ave not been established. Important directions for future
esearch include: developing consistent deﬁnitions, and con-
ucting prospective studies of demographics, motivations,
reatment outcomes, and cost beneﬁts to better understand
he healthcare implications of medical tourism.
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